3,3'-dichlorobenzidine has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hananouchi, M; Hirose, M; Miyata, Y; Mizutani, M; Tatematsu, M | 1 |
| Fukushima, S; Kinoshita, H; Miyata, Y; Murasaki, G; Tsuda, H | 1 |
2 other study(ies) available for 3,3'-dichlorobenzidine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
Topics: 2-Acetylaminofluorene; 3,3'-Dichlorobenzidine; Animals; Benzidines; Biliary Tract Diseases; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cysts; Fluorenes; Formamides; Hepatic Duct, Common; Hyperplasia; Male; Neoplasms, Experimental; Nitrosamines; Papilloma; Rats; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |
Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
Topics: 3,3'-Dichlorobenzidine; Animals; Benzidines; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Drug Synergism; Fatty Liver; Formamides; Liver; Male; Neoplasms, Experimental; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |